Clinical Trial Update: Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial investigating atorvastatin for mitigating cardiotoxicity in acute myeloid leukemia; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Hodgkin Lymphoma

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Assiut University | Conditions: Leukemia, Hodgkin Disease | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING